DUBLIN–(BUSINESS WIRE)–The “Medical Cartridges Market Research Report: By Material Type (Glass, Plastic), Size (Less than 3 ml, 3 ml to 5 ml, 6 ml to 10 ml, More than 10 ml), End User (Pharmaceutical and Biotech Companies, Biomedical Research Organizations) – Global Industry Revenue Estimation to 2030” report has been added to ResearchAndMarkets.com’s offering.
With the increasing prevalence of acute and chronic diseases of all types, be it infection, autoimmune, metabolic, systemic, or cancer, the pharmaceutical industry is booming. As a result, the global medical cartridges market will grow from $920.8 million in 2020 to $1,691.1 million by 2030, at a 6.4% CAGR between 2021 and 2030. A lot of the drugs are given via the parenteral route, which is why the demand for cartridges, syringes, and vials is increasing.
Around 16 billion injections are given every year for contraceptive, blood transfusion, immunization, and curative purposes, according to the World Health Organization (WHO). In this regard, the rising demand for prefilled syringes is driving the medical cartridges market, as the drug inside such devices is essentially contained in a cartridge. Prefilled syringes help prevent needlestick injuries and minimize the wastage of drugs.
Due to the COVID-19 pandemic, the medical cartridges market is witnessing slow growth, as the lockdowns implemented around the world led to the shutdown of cartridge-manufacturing plants. Additionally, social distancing measures and movement restrictions meant that pharmaceutical representatives could not conduct face-to-face interactions with healthcare workers. Moreover, regulatory authorities have, for the moment, stopped approving pharmaceutical products, while many clinical trials have also been halted.
The glass bifurcation is expected to witness the faster growth in the medical cartridges market in the coming years, based on material type. Being inert, glass prevents reactions between the cartridge surface and the drug within. Additionally, glass stops volatile substances from penetrating the surface and mixing with the drug.
In the past, the end user segment of the medical cartridges market was dominated by pharmaceutical and biotech companies. With the growth of the pharma sector, drug, pen injector, and on-body injector manufacturers are increasingly using cartridges. In this regard, the rising adoption of pen injectors, especially by diabetics, is propelling the advance of this category, as are the technological advancements in drug delivery devices.
Presently, Europe generates the highest revenue in the medical cartridges market due to the increasing prevalence of diabetes, itself, in part, owing to the rise in the number of obese people. In the near future, the demand for cartridges will likely surge the most rapidly in Asia-Pacific (APAC). The region is witnessing a boom in its geriatric population, number of people suffering from diabetes, and healthcare expenditure.
- Increasing use of cartridges in diagnostic applications
- Rising production capacity of manufacturers
- Increasing demand for injectable pharmaceutical products
- Growing pharmaceutical industry
- Increasing aging population
- Growing prevalence of acute and chronic diseases
- Impact analysis of drivers on market forecast
- Adoption of alternative drug delivery methods
- Impact analysis of restraints on market forecast
- Increasing awareness about diabetes care
- Stevanato Group
- SCHOTT AG
- Gerresheimer AG
- Nipro Corporation
- Baxter International Inc.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Transcoject GmbH
- Pierrel S.p.A
- AptarGroup Inc.
- Novocol Pharma
For more information about this report visit https://www.researchandmarkets.com/r/phan1u
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900